Boston Scientific, Edwards Lifesciences Face Off in New TAVR Battle
A new patent spat is being fought in Germany by Boston Scientific (NYSE:BSX), who alleges that Edwards Lifesciences (NYSE:EW) is infringing on a patent associated with its Lotus transcatheter heart valve.
Late last month, Boston Scientific filed the patent infringement in Dusseldorf, Germany, charging that Edwards Sapien 3 transcatheter aortic valve replacement is infringing on a European adaptive sealing technology patent, according to a correspondence between MDDIOnline and Boston Scientific spokesperson Thomas Keppler.
Help employers find you! Check out all the jobs and post your resume.
Late last month, Boston Scientific filed the patent infringement in Dusseldorf, Germany, charging that Edwards Sapien 3 transcatheter aortic valve replacement is infringing on a European adaptive sealing technology patent, according to a correspondence between MDDIOnline and Boston Scientific spokesperson Thomas Keppler.
Help employers find you! Check out all the jobs and post your resume.